WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

FAVIPIRAVIR: AN OLD ANTI-INFLUENZA DRUG COULD BE POTENTIAL NEW DRUG FOR COVID-19 TREATMENT

Dr. Pitambar Khanal*

ABSTRACT

The outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); COVID-19 occurred in Wuhan, China in December 2019, and the world health organization (WHO) declared a pandemic by mid-March. COVID-19 has 8,142,604 cases worldwide and 439,755 causalities (June 16, 2020)[1] and no approved medication for treatment. There are urgent needs for the development of new vaccines or drugs. With temporary approval (June 2020) of this pre-existing antiviral drug, Favipiravir in Russia for COVID-19, there is a hope that it could be applied in other countries as well.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More